LIWANLI Innovation Co Ltd (3054) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.056x

Based on the latest financial reports, LIWANLI Innovation Co Ltd (3054) has a cash flow conversion efficiency ratio of -0.056x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-41.53 Million ≈ $-1.31 Million USD) by net assets (NT$743.29 Million ≈ $23.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LIWANLI Innovation Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

LIWANLI Innovation Co Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how LIWANLI Innovation Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

LIWANLI Innovation Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of LIWANLI Innovation Co Ltd ranked by their cash flow conversion efficiency. Explore how high is LIWANLI Innovation Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
CVC Brasil Operadora e Agencia SA:CVCB3	-0.136x
Surya Toto Indonesia Tbk JK:TOTO	-0.028x
HCM Acquisition Corp NASDAQ:HCMA	-0.012x
GPT Healthcare Ltd NSE:GPTHEALTH	0.073x
Al-Bad Massuot Yitzhak Ltd TA:ALBA	0.065x
Byggmästare Anders J Ahlström Holding AB (publ) ST:AJA-B	-0.005x
Nerdy Inc NYSE:NRDY	-0.252x
Baiksan KO:035150	0.011x

Annual Cash Flow Conversion Efficiency for LIWANLI Innovation Co Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of LIWANLI Innovation Co Ltd from 2005 to 2024. View 3054 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$752.96 Million ≈ $23.72 Million	NT$14.20 Million ≈ $447.44K	0.019x	+129.36%
2023-12-31	NT$783.51 Million ≈ $24.68 Million	NT$-50.34 Million ≈ $-1.59 Million	-0.064x	-162.66%
2022-12-31	NT$765.36 Million ≈ $24.11 Million	NT$78.48 Million ≈ $2.47 Million	0.103x	+250.54%
2021-12-31	NT$897.52 Million ≈ $28.28 Million	NT$-61.13 Million ≈ $-1.93 Million	-0.068x	-74.07%
2020-12-31	NT$936.03 Million ≈ $29.49 Million	NT$-36.63 Million ≈ $-1.15 Million	-0.039x	+65.38%
2019-12-31	NT$965.79 Million ≈ $30.43 Million	NT$-109.16 Million ≈ $-3.44 Million	-0.113x	+5.90%
2018-12-31	NT$1.02 Billion ≈ $32.29 Million	NT$-123.09 Million ≈ $-3.88 Million	-0.120x	-291.91%
2017-12-31	NT$1.53 Billion ≈ $48.34 Million	NT$96.03 Million ≈ $3.03 Million	0.063x	-15.97%
2016-12-31	NT$1.51 Billion ≈ $47.66 Million	NT$112.68 Million ≈ $3.55 Million	0.074x	+138.61%
2015-12-31	NT$1.09 Billion ≈ $34.36 Million	NT$34.04 Million ≈ $1.07 Million	0.031x	-91.83%
2014-12-31	NT$1.24 Billion ≈ $39.01 Million	NT$473.04 Million ≈ $14.90 Million	0.382x	+686.36%
2013-12-31	NT$1.38 Billion ≈ $43.43 Million	NT$-89.82 Million ≈ $-2.83 Million	-0.065x	+52.82%
2012-12-31	NT$753.19 Million ≈ $23.73 Million	NT$-104.02 Million ≈ $-3.28 Million	-0.138x	+30.01%
2011-12-31	NT$799.59 Million ≈ $25.19 Million	NT$-157.77 Million ≈ $-4.97 Million	-0.197x	-325.30%
2010-12-31	NT$895.33 Million ≈ $28.21 Million	NT$78.41 Million ≈ $2.47 Million	0.088x	+9.91%
2009-12-31	NT$1.12 Billion ≈ $35.36 Million	NT$89.43 Million ≈ $2.82 Million	0.080x	+4.20%
2008-12-31	NT$666.68 Million ≈ $21.00 Million	NT$50.98 Million ≈ $1.61 Million	0.076x	-3.33%
2005-12-31	NT$462.99 Million ≈ $14.59 Million	NT$36.62 Million ≈ $1.15 Million	0.079x	--

About LIWANLI Innovation Co Ltd

TW:3054 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$145.09 Million

NT$4.61 Billion TWD

Market Cap Rank

#17882 Global

#923 in Taiwan

Share Price

NT$57.10

Change (1 day)

+2.70%

52-Week Range

NT$22.30 - NT$90.30

All Time High

NT$90.30